Your session is about to expire
← Back to Search
Behavioural Intervention
Electro-Acupuncture for High Blood Pressure
N/A
Recruiting
Led By Liang-Wu Fu, MD, PhD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with mild coronary disease, and no significant ECG change reflecting ischemia at rest
Patients with high blood pressure with or without antihypertensive medication
Must not have
Individuals with severe coronary disease (continuous angina)
Cardiac arrhythmias associated with low blood pressure (90 mmHg)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether EA can help lower blood pressure in people with hypertension.
Who is the study for?
This trial is for adults with high blood pressure, which can be with or without current medication. It's also open to those with mild heart disease but no serious ECG changes. However, it's not for pregnant women, individuals with severe heart issues like ongoing chest pain, peripheral vascular disease, certain ECG abnormalities, orthopedic conditions, skin sensitivities to tapes/dressings, very low blood pressure-related arrhythmias or uncontrolled diabetes and psychological conditions.
What is being tested?
The study is testing whether electro-acupuncture (EA) can help lower high blood pressure. Participants will receive either the test EA treatment or a control version of EA. The hypothesis is that EA could have beneficial effects on hypertension based on earlier research in animals and humans.
What are the potential side effects?
Potential side effects from electro-acupuncture may include minor bruising at needle sites, light-headedness during or after treatment, fatigue, headache or temporary soreness. Severe side effects are rare but might involve allergic reactions to the needles' metal if sensitivity exists.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have mild heart disease with no significant changes in my resting ECG.
Select...
I have high blood pressure, with or without medication.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe heart disease with constant chest pain.
Select...
I have heart rhythm problems with low blood pressure.
Select...
I have peripheral vascular disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
blood pressure
Secondary study objectives
Heart rate
Catecholamines
Renin
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Electro-acupuncture testExperimental Treatment2 Interventions
Blood pressure will be recorded before and after each EA treatment for 8 weeks. The course is a once a week 8-week treatment.
Intervention is the active Electro-acupuncture treatment.
Group II: Electro-acupuncture controlExperimental Treatment2 Interventions
Blood pressure will be recorded before and after each EA treatment for 8 weeks. The course is a once a week 8-week treatment.
Intervention is the Electro-acupuncture control treatment.
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
566 Previous Clinical Trials
1,932,888 Total Patients Enrolled
Liang-Wu Fu, MD, PhDPrincipal InvestigatorUniversity of California, Irvine
Shaista Malik, MD, PhD, MPHPrincipal Investigator - University of California, Irvine
Regents of the University of California, University of California-Irvine Medical Center
University Of California (Medical School)
University Ca Irvine Medical Center (Residency)
LiFang Xie, PhD, LAcPrincipal InvestigatorUniversity of California, Irvine
Stephanie Tjen-A-Looi, PhDPrincipal InvestigatorUniversity of California, Irvine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a specific heart condition that shows up on an ECG test.I have severe heart disease with constant chest pain.I have heart rhythm problems with low blood pressure.I have peripheral vascular disease.I have a bone or joint condition.I have diabetes or a mental health condition that may affect my ability to safely perform stress tests.I have mild heart disease with no significant changes in my resting ECG.I have high blood pressure, with or without medication.
Research Study Groups:
This trial has the following groups:- Group 1: Electro-acupuncture control
- Group 2: Electro-acupuncture test
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
High Blood Pressure Patient Testimony for trial: Trial Name: NCT00932139 — N/A